Adriana Zucollo

Title: Adriana Zucollo: Innovator in B-Bradykinin Receptor Antagonists

Introduction

Adriana Zucollo is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of pharmacology, particularly in the development of novel antagonists to the B-bradykinin (B-BK) receptor. Her work addresses critical health issues associated with inflammation and diabetes.

Latest Patents

Adriana Zucollo holds 1 patent related to her innovative research. The patent focuses on antagonists to the B-BK receptor, which exhibit good affinity and selectivity. These antagonists are particularly noteworthy for their partial resistance to enzymatic degradation. The synthesis of B-receptors is induced during inflammation, and symptoms associated with this condition have been observed in diabetic animal models, such as streptozotocin-induced diabetes and spontaneously hypertensive rats. The research confirms the presence of B-BK receptors in these models, and the antagonists developed by Zucollo have shown the ability to abolish vasocontraction induced by B-BK and normalize glycemia levels in diabetic animals.

Career Highlights

Adriana Zucollo has established herself as a key figure in her field through her innovative research and patent contributions. Her work has implications for treating conditions where B-receptors are expressed, particularly in the context of diabetic vasculopathy and other related symptoms.

Collaborations

Throughout her career, Zucollo has collaborated with notable colleagues, including Domenico Recoli and Witold A Neugebauer. These collaborations have further enhanced her research and contributions to the scientific community.

Conclusion

Adriana Zucollo's work in developing B-BK receptor antagonists represents a significant advancement in the treatment of inflammation-related conditions, particularly in diabetic patients. Her innovative approach and dedication to research continue to impact the field positively.